further hampered by the lack of understanding of the underlying molecular changes that cause or contribute to the disease pathology. Of patients with gastroparesis, approximately 36% are idiopathic, 29% diabetic, and 13% postsurgical. 3, 4 As gastric emptying is dependent on an intricate interaction of neural cells, interstitial cells of Cajal (ICCs), platelet-derived growth factor α positive (PDGFRα + ) fibroblasts, and smooth muscle cells (SMCs), it is likely that defects in any of these cell types can contribute to this disease. [5] [6] [7] [8] [9] [10] ICCs are the pacemaker cells in the stomach that transmit slow wave depolarization to the gastric smooth muscle cells. 7, 11 The PDGFRα + fibroblasts are a more recently recognized component of the electrical syncytium that controls gastric contractility. These cells transmit inhibitory neural signals to gastric smooth muscle cells. 5 The major goal of our study was to use transcriptional profiling to identify changes in any of these cell types that may be associated with idiopathic gastroparesis.
Histopathological analyses have suggested decreases in numbers
of ICCs and increases in numbers of CD45 and CD68 positive blood cells in gastric body biopsies from diabetic and idiopathic gastroparesis patients. 12 A similar decrease in ICCs has been observed in mouse models of diabetes. 13 In contrast, it has been reported that there are no changes in the PDGFRα + cell number in either group of gastroparesis patients. 6 It has also been proposed that an increased ratio of M1
relative to M2 macrophages may contribute to delayed gastric emptying in diabetic gastroparesis. 14 In the previous human studies, ICCs have been identified by their immunoreactivity with anti-KIT antibodies (CD117). KIT is a receptor tyrosine kinase found on the surface of ICC that is required for ICC survival and proliferation. 12 Mouse models have suggested that diabetes-induced loss of ICC may result, at least in part, from decreased expression of KIT ligand (KITLG or Stem Cell Factor) from atrophied gastric SMCs. 15 It is not clear if similar changes occur in humans with either diabetic or idiopathic gastroparesis.
All the previous human studies have relied on histological analyses, there have been no definitive quantitative studies that have identified molecular changes that could initiate or contribute to the dysmotility observed in patients with gastroparesis. The goal of this study was to begin to address this gap in our knowledge by using real-time RT-PCR to quantitate changes in mRNA expression that occur within the muscularis layer of the stomach of patients with idiopathic gastroparesis.
| MATERIALS AND METHODS

| Clinical assessment
All procedures were conducted under protocol approved by the Indiana University Institutional Review Board. Informed consents were obtained from control subjects and patients with idiopathic gastroparesis. Idiopathic gastroparesis was defined as patients with symptoms of gastroparesis ≥3 months with delayed gastric emptying by 4-hour gastric scintigraphy or gastric bezoar with undigested foods by upper endoscopy after an overnight fast. Gastric scintigraphy was performed following consumption of a low-fat egg-white meal with imaging at 0, 2, and 4 hours as described previously. 16, 17 Abnormal gastric emptying was defined as 2-hour retention ≥60% or 4-hour retention ≥10%. 
| Full-thickness stomach biopsies
Biopsies from the control group were obtained from non-diabetic individuals without gastroparesis symptoms that were undergoing bariatric weight loss surgery (normal HbA1c level <1 month prior to surgery). Control and gastroparesis subjects were age and sex matched (Table 1) . Surgical full-thickness biopsies from the idiopathic gastroparesis patients were obtained at the time of routine pathological analysis in patients with severe symptoms or at the time of gastric stimulator placement. In each case (control and gastroparesis
Key Points
• Idiopathic gastroparesis is a debilitating disease whose etiology is poorly defined. We aimed to identify transcriptional changes that may contribute to disease pathology.
• Smooth muscle tissue from idiopathic gastroparesis patients had decreased expression of mRNAs encoding several contractile and regulatory proteins, PDGFRα and its ligand PDGFB and Heme oxygenase 1. Conversely, there was no significant change in mRNAs characteristic of interstitial cells of Cajal (ICCs), such as KIT or ANO1.
• Our findings suggest that idiopathic gastroparesis is most commonly associated with transcriptional changes that are indicative of altered smooth muscle cells and PDGFRα + fibroblast cells rather than ICCs.
patients), the biopsy was taken about 10 cm from the pylorus on the anterior aspect midway between the greater and lesser curvatures of the stomach. All biopsies were obtained using linear cutting sta- Contaminating DNA was removed by on-column DNase treatment.
The integrity and purity of the isolated RNA was determined using an Agilent Bioanalyzer. Samples used had an RNA integrity number of >7. Table S1 . These primers detect mRNAs for the following smooth muscle-specific markers: MYH11 (smooth muscle myosin heavy chain), ACTA2 (smooth muscle α-actin), ACTG2 (smooth muscle γ-actin) and CCN1 (calponin). 21 In addition, primers used to detect mRNAs for ATPA4 (which encodes the H+/K+ pump) and GAST (gastrin) were used as markers of parietal and G cells, respectively, within the mucosa. 22 Primers to detect mRNAs for TH (tyrosine hydroxylase), 
| qRT-PCR
| Isolation and polarization of human macrophages
Whole blood (~8 mL) was collected from consenting healthy donors 
| Statistical analysis
Significant differences between the means values of the gastroparesis and control patients were determined using a two-tailed, Welch corrected student t test in order to account for potential differences in the variance in values obtained from control and gastroparesis subjects. P values < .05 were considered significant. Correlations between mRNA levels and clinical parameters were determined using Spearman correlations. Where significant correlations were found, linear regression analysis was performed in order to visualize the correlations graphically. For analysis in which we divided the gastroparesis patients into symptom predominant groups, one-way ANOVA was performed using a Kruskal-Wallis test with a Duns Multiple Comparison post-test.
| RESULTS
Control full-thickness biopsy samples of the stomach were obtained from 14 patients undergoing bariatric weight loss surgery, 5 patients Upper abdominal pain 3.1 ± 1.6
Lower abdominal pain 2.3 ± 1.6
GCSI total score of the 14 control patients were Caucasian and all of the gastroparesis group were Caucasian. Body mass index (BMI) was significantly greater in the control subjects (47.8 ± 8.9 compared with 25.1 ± 6.9).
The clinical characteristics of the 16 patients with idiopathic gastroparesis are provided in Table 1 .
| Dissected muscle layer is free of contaminating mucosa
To confirm that we effectively separated the muscle, submucosal, and mucosal layers during dissection, we performed a focused quantitative real-time reverse transcriptase-PCR (qRT-PCR) analysis of mRNAs whose expression are expected to be localized to specific cell types. This analysis revealed that the muscle layer has high levels of expression of the smooth muscle markers and low to undetectable levels of expression of the mucosal markers, as expected ( Figure 1 ). In contrast, the mucosal layer has high levels of expression of mucosal markers ATPA4 and GAST and very low expression of smooth muscle markers ( Figure 1 ). Neuronal markers are most abundant in the muscle and submucosal layers, consistent with the presence of the myenteric and submucosal nerve plexi, respectively, in these layers ( Figure 1 ).
The submucosal layer is rich in blood vessels, which likely accounts for the relatively high levels of expression of smooth muscle markers that were also observed in this layer, as these proteins would be expected to be expressed in vascular SMCs. These data suggest that the dissected muscularis layer is highly enriched with smooth muscle cells.
| Loss of PDGFRα + fibroblasts but not ICCs in idiopathic gastroparesis
To determine if idiopathic gastroparesis is associated with loss of F I G U R E 1 Separation of muscle, submucosa, and mucosa layers from biopsies. Full-thickness biopsies of stomach were obtained from two control subjects and the muscle, submucosa, and mucosa separated as described in "Methods." RNA was isolated from each layer and the expression of mRNAs encoding proteins characteristic of each layer was quantitated by qRT-PCR. Expression levels relative to an internal control mRNA encoding TATA binding protein (TBP) are indicated. The mean ± SEM of two samples are shown fibroblasts ( Figure 2B ). The expression of PDGFRα mRNA displayed a strong positive correlation to PDGFB mRNA levels but no significant correlation to PDGFA mRNA levels using a Spearman correlation analysis ( Figure 2B ).
| Attenuated expression of mRNAs encoding some proteins characteristic of differentiated contractile SMCs in gastroparesis subjects
To determined if alterations in SMCs may also occur in gastroparesis patients, we examined the expression of mRNAs encoding proteins characteristic of differentiated contractile SMCs. This analysis revealed a specific decrease in expression of MYH11, MYLK1, and PAK1 without any significant change in ACTA2, ACTG2, or CCN1 ( Figure 3 ). Transcription of both MYLK1 and MYH11 is known to be dependent on SRF complexes, whose activity can be modulated by myocardin. [25] [26] [27] We, thus, analyzed the expression of mRNAs encoding these proteins and found that the changes in mRNAs encoding contractile proteins were accompanied by significantly decreased expression of SRF but not myocardin transcripts ( Figure 3 ). The expression levels of MYLK and MYH11 transcripts were significantly correlated with expression of SRF transcripts, across all of our human samples (Figure 4 ).
| Reduced expression of mRNAs encoding anti-inflammatory proteins in gastroparesis subjects
To evaluate potential changes in inflammation and macrophage activation in idiopathic gastroparesis, we examined the expression of mRNAs encoding inflammatory cytokines IL1β and TNFα, markers of macrophages, CD68, CD86, MRC1(CD206), HMOX1(HO-1), and 
qRT-PCR analysis of mRNA encoding proteins and transcription factors characteristic of contractile SMCs. Total RNA was isolated from the muscle layer of biopsies obtained from 14 control subjects and 16 subjects with idiopathic gastroparesis and analyzed by qRT-PCR as described in Figure 2 CLEC7A, and anti-inflammatory cytokines, such as TGFβ ( Figure 5 ). In order to try to distinguish M1 from M2 macrophages, we first examined the relative expression of several macrophage markers in human macrophages derived from peripheral blood mononuclear cells (PBMCs) from healthy donors. Macrophages were polarized into M1 or M2 macrophages as described in methods. This analysis identified MRC1, MRC2, HMOX1, and CLEC7A as relatively selective markers of M2 macrophages compared with M1 macrophages ( Figure S1 ). However, each of these markers is also expressed at relatively high levels in unstimulated macrophages (M0; Figure S1 ). Of the genes examined, only TNFα was selectively expressed by M1 macrophages as compared with M2 macrophages ( Figure S1 ). Analysis of mRNA isolated from the gastric muscle layer of control and gastroparesis subjects did not reveal any significant changes in mRNAs encoding proinflammatory cytokines IL1β and TNFα, although we did observe decreased expression of the immunosuppressive cytokine TGFβ1 ( Figure 5 ). We also observed decreased expression of the pan monocyte/macrophage marker CD68 and decreased expression of HMOX1, which encodes heme oxygenase 1 (HO-1), without any significant change in other M2 macrophage selective markers, CLEC7A and MRC1 ( Figure 5 ).
| Altered expression of mRNAs encoding neural markers in gastroparesis subjects
Previous studies have observed decreases in inhibitory nerves in individual patients with gastroparesis, although as a group there was no statistical difference between control and gastroparesis patients. 12 To evaluate neuronal changes in our samples, we assessed levels of mRNAs encoding markers of inhibitory nerves, VIP (vasoactive intestinal peptide), NOS1 (neural nitric oxide synthase), and excitatory nerves, CHAT (choline O-acetyltransferase) and SLC18A3 (solute carrier protein 18A3 (VAChT) which transports acetyl choline into secretory vesicles) ( Figure 6A ). This analysis revealed a small but significant increase in NOS1 and CHAT mRNA in samples from gastroparesis patients as compared with controls ( Figure 6A ).
| Molecular changes correlate with PAGI-SYM subscores
The average percentage of food remaining in the stomachs of our gastroparesis patients 4 hours after ingestion of a standard low fat egg-white meal was 29 ± 19% (Table 1) . This large variability in gastric emptying allowed us to use Spearman correlation analysis to deter- This analysis revealed a significant correlation between the PAGI-SYM Fullness/Satiety subscores and expression levels of MYLK1, ANO1, and PDGFRα (Table S2 , with Spearman r values of −.53, −.55, and .54, respectively, Figure 6B ). As our data revealed significant heterogeneity within the gastroparesis patient population, we determined if this heterogeneity may be due to different groups of patients that could be identified based on their predominant symptoms (vomiting predominant, VP; dyspepsia predominant, DP; or regurgitation predominant, RP; Table 1 ). However, when we separated patients based on these predominant symptoms, we did not observe any significant differences between the symptom groups ( Figure 7 ).
| DISCUSSION
qRT-PCR analysis of RNA isolated from the muscularis layer of gastric biopsies obtained from patients with idiopathic gastroparesis and control subjects revealed changes in mRNAs that would indicate that idiopathic gastroparesis may be associated with changes in PDGFRα + fibroblasts and SMCs rather than a loss of ICCs. These findings are in contrast to previously published immunohistological studies which showed decreased numbers of ICCs but no change in the number of PDGFRα + fibroblasts in idiopathic gastroparesis subjects. 6, 12 In this study, we assessed both KIT and ANO1 as markers of ICCs. KIT is a receptor tyrosine kinase expressed on ICCs that is required for their survival. Antibodies to KIT were used in the previous immunohistological studies to quantitate ICC numbers. 12 ANO1
encodes a calcium-regulated chloride channel that is specifically expressed in ICC and required for slow wave generation in the stomach. 28 Previous studies have shown that ANO1 positive ICCs are also decreased in diabetic gastroparesis and this is associated with altered splicing of ANO1 resulting in the generation of an ANO1 transcript lacking exons 1 and 2 that encode a protein with altered channel activity. 29 The qRT-PCR primers used in our study do not distinguish these two splice variants and thus represent total ANO1 mRNA levels. Although we did not observe any significant changes in either KIT or ANO1 mRNA expression in idiopathic gastroparesis patients compared with controls when we compared the relative expression of these two mRNAs in all samples, we did observe a statistically significant correlation between the two, which would be expected as they are both markers of ICCs (Figure 2A) . Consistent with the lack of changes in ICC markers, we also did not observe any significant change in KITLG in the idiopathic gastroparesis patient samples ( Figure 2A ). However, we did observed a positive correlation between ANO1 and KITLG expression which would support a role of KITLG in maintaining ICCs. Similarly, we observed a strong correlation between PDGFRα and PDGFB mRNA levels across all samples ( Figure 2B ). This correlation between receptor and ligand may suggest that signaling through the PDGFRα receptor is required to maintain the intramuscular population of PDGFRα+ fibroblasts rather than both receptor and ligand being expressed by the same cells. This would be consistent with the known role of PDGFB in promoting cell proliferation.
30,31
Analysis of mRNAs encoding SMC contractile proteins would suggest that there is not a generalized atrophy of SMCs in most patients with idiopathic gastroparesis, but rather there are decreases in mRNAs encoding specific contractile and regulatory proteins ( Figure 3 ). In particular, we observed significant decreases in mRNAs encoding smooth muscle myosin heavy chain (MYH11), myosin light chain kinase (MYLK1) and p21 activated kinase 1 (PAK1) ( Figure 3 ).
As myosin (MYH11) is required for smooth muscle contraction, and phosphorylation of myosin light chain subunit by myosin light chain kinase (MYLK1) is required to stimulate myosin's ATPase activity in response to contractile agonists, decreases in mRNAs encoding these proteins would be expected to directly impair contractility.
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Similarly, PAK1 also phosphorylates myosin light chains, in addition to the myosin phosphatase targeting subunit MYPT1, to promote smooth muscle contractility. 33 Studies in mice have shown that decreased expression of Myh11, Mylk1, or PAK1 each individually result in impaired SMC contractility and GI motility. Although we did not observe a significant change in myocardin mRNA in samples from patients with idiopathic gastroparesis, we did see a significant decrease in SRF mRNA (Figure 3) . We also noted a tight correlation between levels of SRF and MYLK1 and MYH11 mRNAs (Figure 4 ), which would be consistent with previous studies that showed that expression of the MYLK1 gene is dependent on an SRF binding site in its first intron 25 and that expression of MYH11
is also SRF dependent. 25 Unexpectedly, the decrease in SRF did not result in a significant attenuation of expression of other contractile proteins that are also SRF dependent. This may reflect differences in the sensitivity of each of the genes to levels of SRF.
Immunohistological studies have suggested that in diabetic gastroparesis, a defect in M2 macrophages may be contributing to the disease pathology. 14,37 Alternatively activated M2 macrophages express high levels of heme oxygenase-1 and can thus protect against oxidative stress. 38 Although our qRT-PCR analysis did not reveal an overall decrease in M2 macrophages as determined by M2 selective markers MRC1 and CLEC7A, we did observe a significant decrease in HMOX1 mRNA that encodes heme oxygenase-1 protein ( Figure 5 ).
This finding would suggest that similar to subjects with diabetic gastroparesis, subjects with idiopathic gastroparesis may also be more susceptible to oxidative damage. However, this does not appear to result in marked damage to neurons, to affect stomach motility, as mRNA encoding markers of both inhibitory and excitatory neurons were slightly elevated in gastroparesis patients ( Figure 6A ). The significance of the elevation in both inhibitory and excitatory neural markers is not immediately apparent, but could represent compensatory changes involving increased neural proliferation/differentiation that have occurred as a consequence of the disease. This neural plasticity is consistent with the findings of a recent study showing that in adult mice, intestinal neurons are continually dying and being replaced with new neurons.
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Despite the numerous significant changes in mRNA expression that we observed in the stomach muscularis layer of patients with idiopathic gastroparesis, it is not clear how these changes relate to patient symptoms and underlying pathology. Although it is readily F I G U R E 4 Relationship between expression of contractile proteins and the transcription factors that regulate their expression. Data from both control and gastroparesis subjects, shown in Figure 3 , were analyzed by Spearman's correlation and linear regression analyses to examine the relationship between expression of MYKL, MYH11, and transcription factors SRF and myocardin. These analyses revealed a highly significant positive correlation between the expression of SRF and MYLK1 and MYH11 apparent how many of the changes could affect gastric motility, we did not find significant correlations between individual mRNA expression and gastric emptying (Table S2) (Table S2 ). The positive correlation we observed between KIT and gastric retention (Spearman r value of .745, Figure 6B ) is rather puzzling, given that the gastroparesis patients as a group did not have significantly different levels of KIT expression compared with control subjects (Figure 2A ). This positive correlation would suggest that higher KIT levels are associated with decreased gastric motility, which is contrary to the expected result. 40, 41 There are a number of possible explanations for this observation. As we did not observe an overall decrease in KIT levels in gastroparesis patients compared with control subjects, this statistical correlation between the small variations in KIT levels and gastric emptying may not be biologically meaningful. Alternatively, as we did not observe a similar correlation between ANO1 and gastric emptying, and both F I G U R E 5 qRT-PCR analysis of mRNA encoding proteins related to inflammation and macrophage polarity. Total RNA was isolated from the muscle layer of biopsies obtained from 14 control subjects and 16 subjects with idiopathic gastroparesis and analyzed by qRT-PCR as described in Figure 2 KIT and ANO1 are markers of ICC, this would suggest that gastric emptying is not correlating to ICC number but more specifically with KIT expression. One possible basis for this is that KIT is not exclusively expressed on ICC but is also expressed on several hematopoietic cells, including mast cells. 42 The positive correlation between KIT expression and delayed gastric emptying could thus represent a correlation between increased numbers of mast cells as compared with ICC. We observed significant negative correlations between MYLK1 and ANO1 expression and the fullness/satiety PAGI-SYM subscore ( Figure 6B ). This suggests that these symptoms are associated with decreased SMC contractility and/or altered activity of ICCs. Conversely, PDGFRα receptor levels showed a significant, although weak, positive correlation with the fullness/satiety PAGI-SYM subscore ( Figure 6B ). This would suggest that the higher the PDGFRα receptor expression the worse the gastric emptying.
This may reflect the role of PDGFRα+ fibroblasts in mediating inhibitory neural input to SMCs, which would be likely to attenuate contractility.
Despite being able to observe significant changes in mRNA expression between the gastroparesis and control subjects, our data also revealed significant heterogeneity within the gastroparesis patient population. The different symptom predominant groups of patients do not seem to account for this heterogeneity (Figure 7 ). Our analyses identified several individual patients that had unique changes in mRNA expression which may provide insight into the specific pathophysiology of these patients. For example, one patient had markedly lower expression of ICC markers and had one of the lowest levels of KITLG expression, suggesting that ICC loss may be contributing to this patient's pathology. In contrast, another patient had very low levels of expression of several contractile proteins which would be indicative of a more generalized SMC atrophy in this subject. These findings highlight the need for a more global analysis of the molecular changes that occur in the stomach of subjects with idiopathic gastroparesis in order to be able to design a more personalized rational therapeutic approach for each individual patient.
Although our qRT-PCR data suggest that idiopathic gastroparesis may be associated with changes in PDGFRα + fibroblasts and
SMCs rather than a loss of ICCs, this interpretation must be viewed within the limitations of our study. First, this conclusion is inferred from changes in mRNA expression rather than directly counting the cells themselves within the stomach muscularis. However, this may be both a weakness and a strength of our study as the muscle tissue from our biopsy samples is frozen and ground to a powder before isolation of mRNA this generates a very homogeneous sample. To F I G U R E 6 qRT-PCR analysis of mRNA encoding proteins related to neurons and correlations between mRNA expression and clinical symptoms. A. Total RNA was isolated from the muscle layer of biopsies obtained from 14 control subjects and 16 subjects with idiopathic gastroparesis and analyzed by qRT-PCR as described in Figure 2 . B. Linear regression analysis of the indicated mRNAs and PAGI-SYM subscores, or gastric retention, together with the Spearman r values and P values obtained from correlation analysis shown in Table S2 obtain similar homogeneity using immunohistology, it is necessary to analyze a large number of sections taken from many different regions of the biopsy. Counting cells using immunohistology is also greatly affected by the orientation of the sections relative to the different muscle layers. The homogeneity of our sample does, however, preclude us from determining in which muscle layer observed changes occur. A second limitation of our study is that the control patient population used in the study consisted of obese patients undergoing bariatric weight loss surgery. This raises the possibility that obesity itself may be affecting the cell populations or cell functions which could mask some of the effects of gastroparesis or could in itself be causing some of the changes we observed. Although this is a possibility, this is unlikely to explain why conclusions from our qRT-PCR analysis differ from those reported based on immunohistology, as these previous studies also used obese control subjects.
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Unfortunately, it is not ethically feasible to obtain full-thickness stomach biopsies from any other routinely available patient population, hence identifying possible obesity-induced changes will await F I G U R E 7 qRT-PCR analysis of mRNA expression segregated based on symptom predominant phenotype. Graphs shown are replots of the mRNA expression data shown in Figures 2 and 3 , in which the gastroparesis subjects were divided into those whose symptoms were vomiting predominant (VP), dyspepsia predominant (DP), or regurgitation predominant (RP) ( Table 1) . A one-way ANOVA, using a Kruskal-Wallis test with a Duns Multiple Comparison post-test, was performed to evaluate significant differences from control subjects and between gastroparesis groups. P values representing overall differences of the gastroparesis subjects from control subjects are shown; asterisks indicate individual groups that were significantly different from the controls, as determined by the Duns Multiple Comparison test. None of the gastroparesis groups were found to be significantly different from each other future studies in which a sufficiently large cohort of other control subjects are identified and analyzed. Finally, it is important to note that as all of the gastroparesis patients we analyzed have wellestablished disease, it is not possible to determine if the alterations in mRNA expression are causal or a consequence of the disease.
In summary, the data described in this study provide the first detailed quantitative analysis of molecular changes that occur in the stomach of patients with idiopathic gastroparesis. Results from our studies suggest that changes in specific SMC contractile proteins may contribute to the dysmotility seen in idiopathic gastroparesis.
Additional changes in numbers of PDGFRα + fibroblasts may be further contributing to the dysmotility. The studies also highlight the potential of using molecular profiling to better identify the underlying pathology of individual gastroparesis patients which can then be used to design a more rational personalized therapeutic strategy.
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